Verve Therapeutics, Inc. (VERV) Earnings
|
Expand Research on VERV
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +24.4% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -6.4% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/7/25  |
Q225 | N/A | -$0.69 | N/A | N/A | $4.27M | N/A | N/A | N/A | ||
| 5/14/25 | Q125 | -$0.35 | -$0.65 | +$0.30 | $32.98M | $7.88M | N/A |  | | Details | |
| 5/13/25 |
Q125 | N/A | -$0.65 | N/A | N/A | $7.88M | N/A | N/A | N/A | ||
| 5/12/25 |
Q125 | N/A | -$0.65 | N/A | N/A | $7.88M | N/A | N/A | N/A | ||
| 5/9/25 |
Q125 | N/A | -$0.65 | N/A | N/A | $7.88M | N/A | N/A | N/A | ||
| 5/7/25 |
Q125 | N/A | -$0.65 | N/A | N/A | $7.88M | N/A | N/A | N/A | ||
| 2/27/25 |
Q424 | -$0.58 | -$0.68 | +$0.10 | $13.08M | $3.57M | N/A | | | Details | |
| 11/5/24 | Q324 | N/A | -$0.68 | N/A | N/A | $2.75M | N/A | N/A | N/A |
